Use of Tamsulosin to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery

PHASE3TerminatedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

November 21, 2019

Study Completion Date

November 21, 2019

Conditions
Postoperative Urinary Retention
Interventions
DRUG

Tamsulosin hydrochloride

Participants will receive 0.4 mg/day tamsulosin hydrochloride from 5 days prior to the operation until hospital discharge.

OTHER

Placebo

The placebo capsule matching the active study drug will be given daily from 5 days prior to the operation until hospital discharge.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER